Markets

Dr. Reddy's Laboratories Ltd (RDY) Ex-Dividend Date Scheduled for July 10, 2013

Dr. Reddy's Laboratories Ltd ( RDY ) will begin trading ex-dividend on July 10, 2013. A cash dividend payment of $0.2644 per share Shareholders who purchased RDY stock prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 15.26% increase over the prior year.

The previous trading day's last sale of RDY was $36.77, representing a -5.09% decrease from the 52 week high of $38.74 and a 28.03% increase over the 52 week low of $28.72.

RDY is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and Pfizer, Inc. ( PFE ). RDY's current earnings per share, an indicator of a company's profitability, is $1.9. Zacks Investment Research reports RDY's forecasted earnings growth in 2014 as 10.81%, compared to an industry average of -7.5%.

For more information on the declaration, record and payment dates, visit the RDY Dividend History page.

Interested in gaining exposure to RDY through an Exchange Traded Fund [ETF]?

The following ETF(s) have RDY as a top-10 holding:

  • EGShares Health Care GEMS ETF ( HGEM )
  • First Trust Exchange-Traded Fund II First Trust BICK Index Fun ( BICK ).

The top-performing ETF of this group is HGEM with an increase of 4.71% over the last 100 days. It also has the highest percent weighting of RDY at 4.95%.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

JNJ BICK RDY PFE

Other Topics

Stocks